Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
ACR, adjacent, Amgen, apparent, approach, ARB, articular, Attention, beneficiary, biomarker, burden, compensatory, composite, consecutive, debilitating, degradation, digest, erythrocyte, fall, FIN, Fujisawa, Interpretation, invade, issuable, membrane, merit, movement, OSCAR, owed, partnering, Pfizer, prepaid, provision, resale, rescue, rotating, score, screening, secondary, sedimentation, service, shape, shelf, subordinated, successor, suitable, traditional, unpaid, unused, variable
Removed:
automatic, bearing, billion, capitalized, choose, closing, complementary, computing, consideration, denominator, dilutive, distribute, export, fact, forma, Genentech, import, indirect, ineffective, invoiced, Leasing, limitation, liquidity, nominal, numerator, Phoenix, pro, qualifying, reconciliation, redeemable, registered, relation, represent, repurchase, retroactive, salary, twelve, unbilled, underwriting, underwritten, Vice, yield
Filing tables
Filing exhibits
- 10-K Annual report
- 10.25 EX-10.25 2ND Loan Modification Agreement
- 10.26 EX-10.26 3RD Loan Modification Agreement
- 10.27 EX-10.27 Negative Pledge Agreement Dated 12/29/03
- 23.01 EX-23.01 Consent of Ernst & Young
- 24.01 EX-24.01 Powers of Attorney
- 31.1 EX-31.1 Section 302 Certification of the CEO
- 31.2 EX-31.2 Section 302 Certification of the CFO
- 32 EX-32 Section 906 Certification of the CEO & CFO
AGIX similar filings
External links